missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PDLIM1 Antibody, Novus Biologicals™
  7. 18639581

PDLIM1 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP2-98546-100ul

 View more versions of this product

Product Code. 18639581

  • 326.00€ / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

PDLIM1 Polyclonal antibody specifically detects PDLIM1 in Human samples. It is validated for Western Blot, Immunoprecipitation
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PDLIM1
Polyclonal
Western Blot 1:500-1:2000, Immunoprecipitation 0.5-2 μL/mg of lysate
CLIM1carboxyl terminal LIM domain protein 1, CLP-36, CLP36carboxy terminal LIM domain protein 1, C-terminal LIM domain protein 1, elfin, enigma, hCLIM1, LIM domain protein CLP-36, PDZ and LIM domain 1, PDZ and LIM domain 1 (elfin), PDZ and LIM domain protein 1
Produced in rabbits immunized with E. coli-derived Human PDLIM1 fragment.
100 μg
Cancer, Endocrinology
9124
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG
Western Blot, Immunoprecipitation
Unconjugated
PBS (pH 7.0)
Rabbit
Antigen and protein A Affinity-purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.